Development of avian sarcoma and leukosis virus-based vector-packaging cell lines
- Univ. of California, Berkeley (USA)
The authors have constructed an avian leukosis virus derivative with a 5{prime} deletion extending from within the tRNA primer binding site to a SacI site in the leader region. The aim was to remove cis-acting replicative and/or encapsidation sequences and to use this derivative, RAV-1{Psi}{sup {minus}}, to develop vector-packaging cell lines. They show that RAV-1{Psi}{sup {minus}} can be stably expressed in the quail cell line QT6 and chicken embryo fibroblasts and that it is completely replication deficient in both cell types. Moreover, they have demonstrated that QT6-derived lines expressing RAV-1{Psi}{sup {minus}} can efficiently package four structurally different replication-defective v-src expression vectors into infectious virus, with very low or undetectable helper virus release. These RAV-{Psi}{sup {minus}}-expressing cell lines comprise the first prototype avian sarcoma and leukosis virus-based vector-packaging system. The construction of our vectors has also shown us that a sequence present within gag, thought to facilitate virus packaging, is not necessary for efficient vector expression and high virus production. They show that quantitation and characterization of replication-defective viruses can be achieved with a sensitive immunocytochemical procedure, presenting an alternative to internal selectable vector markers.
- DOE Contract Number:
- AC03-76SF00098
- OSTI ID:
- 6522951
- Journal Information:
- Journal of Virology; (USA), Vol. 62:3; ISSN 0022-538X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Biological and biochemical studies on the inactivation of avian oncoviruses by ultraviolet irradiation
Induction of methotrexate resistance by retroviral-mediated transfer of a mutant dihydrofolate reductase gene